Regarding phosphorylated Erk1/2, in a study of prostate cancer patients, a significant increase was observed in CRPC compared to primary prostate cancer, confirming the association between phosphorylated Erk1/2 and biochemical recurrence [35]. Here, MAPK3 is linked to prostate cancer.